4Suppes T, Hirschfeld RM, Vieta E, et al. QuetJaplne for the treatment of bipolar II depression: analysis of data from two ran - domized, double - blind, placebo - controlled stud- ies. World J Biol Psychiatry, 2008,9(3) : 198 - 211.
1[1]Small JG,Hirsh SR,Arvanitis LA,et al.Quetiapine in patients with schizophrenia:a high dose and low dose double-blind comparison with placebo.Arch Gen Psychiatry,1997,54:549
2Silverstone PH, Silverstone T. A review of acute treatments for bipolar depression. Int Clin Psychopharmacol. 2004; 19(3): 113-124.
3Keck PE. Bipolar depression: a new role for atypical antipsy-chotics? Bipolar Disord. 2005:7 (Suppl. 4): 34-40.
4Chou JC, Solhkhah R, Serper M. Clinical research on antipsychotics in bipolar disorder. J Psychiatr Pract. 2003:6 (6) :310-321.
5Yatham LN. Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am. 2005; 28 (2) : 325-347.
6Berk M, Dodd S. Efficacy of atypical antipsychotics in bipolar disorder. Drugs, 2005; 65 (2): 257-269.
7Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry, 2003; 60 ( 11 ) : 1979-1088.
8Sanger TM, Grundy SL, Gibson PJ, et al. long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry, 2001; 62(4) : 273-281.
9Amsterdam JD, Shults J. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine intial therapy of bipolar type I and type Ⅱ major depression-lack of manic induction. J Affect Disord. 2005; 87 (1): 121-130.
10Keck PE Jr, Corya SA, Ahshuler LL, et al. Analyses of treatment-emergent mania with olanzapine/fluoxetlne combination in the treatment of bipolar depression. J Clin Psychiatry,2005; 66 (5): 611-616.